Utilization of hyperestrogenic therapies in systemic lupus erythematosus

Carlsten, 1993, Histocompatibility complex gene products and exposure to oestrogen: Two independent disease accelerating factors in murine lupus, Scand J Immunol, 38, 341, 10.1111/j.1365-3083.1993.tb01736.x Roubinian, 1978, Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice, J Exp Med, 147, 1568, 10.1084/jem.147.6.1568 Sánchez-Guerrero, 1997, Past use of oral contraceptives and the risk of developing systemic lupus erythematosus, Arthritis Rheum, 40, 804, 10.1002/art.1780400505 Sánchez-Guerrero, 1995, Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus, Ann Intern Med, 122, 430, 10.7326/0003-4819-122-6-199503150-00005 Lahita, 1982, Estrogen metabolism in systemic lupus erythematosus: Patients and family members, Arthritis Rheum, 25, 843, 10.1002/art.1780250726 Bruce, 1997, Sex hormones in systemic lupus erythematosus: a controversy for modern times, J Rheumatol, 24, 1461 Pimstone, 1966, Systemic lupus erythematosus exacerbated by oral contraceptives, S Afr J Obstet Gynecol, 3, 62 Chapel, 1971, Oral contraceptives and exacerbation of lupus erythematosus, Am J Obstet Gynecol, 110, 366, 10.1016/0002-9378(71)90730-7 Travers, 1978, Oral contraceptive therapy and systemic lupus erythematosus, J Rheumatol, 5, 448 Garovich, 1980, Oral contraceptives and systemic lupus erythematosus, Arthritis Rheum, 23, 1396, 10.1002/art.1780231213 Furukawa, 1991, Oral contraceptive-induced lupus erythematosus in a Japanese woman, J Dermatol, 18, 56, 10.1111/j.1346-8138.1991.tb03041.x Jungers, 1982, Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus, Arthritis Rheum, 25, 618, 10.1002/art.1780250603 Julkunen, 1991, Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE, Scand J Rheumatol, 20, 427, 10.3109/03009749109096822 Buyon, 1995, Can women with systemic lupus erythematosus safely use exogenous estrogens?, J Clin Rheumatol, 1, 205, 10.1097/00124743-199508000-00002 Petri, 2005, Combined oral contraceptives in women with systemic lupus erythematosus, N Engl J Med, 353, 2550, 10.1056/NEJMoa051135 Sánchez-Guerrero, 2005, A trial of contraceptive methods in women with systemic lupus erythematosus, N Engl J Med, 353, 2539, 10.1056/NEJMoa050817 Mok, 1999, Do flares of systemic lupus erythematosus decline after menopause?, Scand J Rheumatol, 28, 357, 10.1080/03009749950155346 Mok, 2001, Use of exogenous estrogens in systemic lupus erythematosus, Semin Arthritis Rheum, 30, 426, 10.1053/sarh.2001.22498 Sánchez-Guerrero, 2001, Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus, Am J Med, 111, 464, 10.1016/S0002-9343(01)00885-3 Urowitz, 2006, The effect of menopause on disease activity in systemic lupus erythematosus, J Rheumatol, 33, 2192 Fernández, 2005, Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women, Arthritis Rheum, 52, 1655, 10.1002/art.21048 Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Manzi, 1997, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study, Am J Epidemiol, 145, 408, 10.1093/oxfordjournals.aje.a009122 Asanuma, 2003, Premature coronary-artery atherosclerosis in systemic lupus erythematosus, N Engl J Med, 349, 2407, 10.1056/NEJMoa035611 Roman, 2003, Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus, N Engl J Med, 349, 2399, 10.1056/NEJMoa035471 Arden, 1994, Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE), Lupus, 3, 11, 10.1177/096120339400300104 Kreidstein, 1997, Hormone replacement therapy in systemic lupus erythematosus, J Rheumatol, 24, 2149 Buyon, 2005, The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial, Ann Intern Med, 142, 953, 10.7326/0003-4819-142-12_Part_1-200506210-00004 Sánchez-Guerrero, 2007, Menopause hormonal therapy in women with systemic lupus erythematosus, Arthritis Rheum, 56, 3070, 10.1002/art.22855 Fernández, 2006, Systemic lupus erythematosus in a multiethnic cohort (LUMINAXXXIX): relationship between hormone replacement therapy and disease activity over time, Lupus, 15, 621, 10.1177/0961203306071924 Fernández, 2007, Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women, J Clin Rheumatol, 13, 261, 10.1097/RHU.0b013e318156bbf5 Beerendonk, 1998, Ovarian hyperstimulation syndrome: facts and fallacies, Obstet Gynecol Surv, 53, 439, 10.1097/00006254-199807000-00024 Ben-Chetrit, 1994, Systemic lupus erythematosus induced by ovulation induction treatment, Arthritis Rheum, 37, 1614, 10.1002/art.1780371109 Casoli, 1997, Fatal exacerbation of systemic lupus erythematosus after induction of ovulation, J Rheumatol, 24, 1639 Benshushan, 1995, Ovulation induction with clomiphene citrate complicated by deep vein thrombosis, Eur J Obstet Gynecol Reprod Biol, 62, 261, 10.1016/0301-2115(95)02193-B Huong, 2002, Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles, Semin Arthritis Rheum, 32, 174, 10.1053/sarh.2002.37212 Guballa, 2000, Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome, Arthritis Rheum, 43, 550, 10.1002/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y